Lista de obras - Silvia Priori - Dominio Público Uruguay

2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

article

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

article

A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene

artículo científico publicado en 2005

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolo

artículo científico publicado en 2006

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

artículo científico publicado en 2006

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--excutive summary

artículo científico publicado en 2007

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiolog

artículo científico publicado en 2006

Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia.

artículo científico publicado en 2016

Age of First Arrhythmic Event in Brugada Syndrome: Data From the SABRUS (Survey on Arrhythmic Events in Brugada Syndrome) in 678 Patients

artículo científico publicado en 2017

An International Multicenter Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition

scientific article published on 16 January 2020

Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator

artículo científico publicado en 2022

Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.

artículo científico publicado en 2004

Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor.

artículo científico publicado en 2005

Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism

scientific journal article

CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia.

artículo científico publicado en 2013

Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia.

artículo científico publicado en 2010

Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitati

artículo científico publicado en 2005

Cell identity and nucleo-mitochondrial genetic context modulate OXPHOS performance and determine somatic heteroplasmy dynamics

artículo científico publicado en 2020

Characterization and Management of Arrhythmic Events in Young Patients With Brugada Syndrome

scientific article published on 01 April 2019

Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.

artículo científico publicado en 2002

Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy

artículo científico publicado en 2009

Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org)

artículo científico publicado en 2009

ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe.

artículo científico publicado en 2004

Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls

artículo científico publicado en 2020

Ethnic differences in patients with Brugada syndrome and arrhythmic events: New insights from Survey on Arrhythmic Events in Brugada Syndrome

artículo científico publicado en 2019

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice ...

artículo científico publicado en 2007

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by rep

artículo científico publicado en 2007

Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology

artículo científico publicado en 2004

Fever-Related Arrhythmic Events in the Multicenter Survey on Arrhythmic Events in Brugada Syndrome (SABRUS).

artículo científico publicado en 2018

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

artículo científico publicado en 2003

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

artículo científico publicado en 2003

Gating Properties of SCN5A Mutations and the Response to Mexiletine in Long-QT Syndrome Type 3 Patients

artículo científico publicado en 2007

Gender differences in patients with Brugada syndrome and arrhythmic events: Data from a survey on arrhythmic events in 678 patients

artículo científico publicado en 2018

Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3.

artículo científico publicado en 2016

Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice.

artículo científico publicado en 2005

Guía ESC 2015 sobre el tratamiento de pacientes con arritmiasventriculares y prevención de la muerte súbita cardiaca

Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica

HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations

artículo científico publicado en 2008

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

artículo científico

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

artículo científico publicado en 2011

High Efficacy of β-Blockers in Long-QT Syndrome Type 1

article by G. Michael Vincent et al published 20 January 2009 in Circulation

Induced pluripotent stem cell-derived cardiomyocytes and long QT syndrome: is personalized medicine ready for prime time?

artículo científico publicado en 2011

Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis

artículo científico publicado en 2011

KCNJ2 mutation in short QT syndrome 3 results in atrial fibrillation and ventricular proarrhythmia

artículo científico publicado en 2013

Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome

artículo científico publicado en 2004

Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome

artículo científico publicado en 2003

Long QT syndrome and pregnancy

artículo científico publicado en 2007

Long QT syndrome in adults.

artículo científico publicado en 2007

Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation

artículo científico publicado en 2002

Long-QT syndrome after age 40.

artículo científico publicado en 2008

Medical Practice Guidelines Separating science from economics

artículo científico publicado en 2003

Modulating effects of age and gender on the clinical course of long QT syndrome by genotype

artículo científico publicado en 2003

Outcome parameters for trials in atrial fibrillation: executive summary

artículo científico publicado en 2007

Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association

artículo científico publicado en 2007

Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome.

artículo científico publicado en 2010

Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE

article

Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE.

artículo científico publicado en 2016

Profile of Brugada Syndrome Patients Presenting with Their First Documented Arrhythmic Event. Data from the Survey on Arrhythmic Events in BRUgada Syndrome (SABRUS).

artículo científico publicado en 2018

Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group

artículo científico publicado en 2005

Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis

artículo científico publicado en 2006

Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome

artículo científico publicado en 2008

Risk factors for recurrent syncope and subsequent fatal or near-fatal events in children and adolescents with long QT syndrome

artículo científico publicado en 2011

Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals

artículo científico publicado en 2011

Risk of death in the long QT syndrome when a sibling has died

artículo científico publicado en 2008

Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.

artículo científico publicado en 2012

Risk stratification in the long-QT syndrome.

artículo científico publicado en 2003

Short communication: flecainide exerts an antiarrhythmic effect in a mouse model of catecholaminergic polymorphic ventricular tachycardia by increasing the threshold for triggered activity.

artículo científico publicado en 2011

Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age.

artículo científico publicado en 2014

Time-to-first appropriate shock in patients implanted prophylactically with an implantable cardioverter-defibrillator: data from the Survey on Arrhythmic Events in BRUgada Syndrome (SABRUS)

scientific article published on 01 May 2019

Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model

artículo científico publicado en 2008

Universal definition of myocardial infarction

artículo científico publicado en 2007

Update of the guidelines on sudden cardiac death of the European Society of Cardiology

artículo científico publicado en 2003

Viral gene transfer rescues arrhythmogenic phenotype and ultrastructural abnormalities in adult calsequestrin-null mice with inherited arrhythmias

artículo científico publicado en 2012

[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the

artículo científico publicado en 2016

[Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]

artículo científico publicado en 2004

[Guidelines for cardiac pacing and cardiac resynchronization therapy]

scientific article published on 01 May 2008

[Guidelines in cardiac pacing and resynchronization therapy].

artículo científico publicado en 2007

[Guidelines on the management of stable angina pectoris: executive summary]

scientific article published on 01 August 2006

Lista de obras de Silvia Priori

2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolo

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--excutive summary

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiolog

Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia.

Age of First Arrhythmic Event in Brugada Syndrome: Data From the SABRUS (Survey on Arrhythmic Events in Brugada Syndrome) in 678 Patients

An International Multicenter Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition

Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator

Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.

Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor.

Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism

CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia.

Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia.

Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitati

Cell identity and nucleo-mitochondrial genetic context modulate OXPHOS performance and determine somatic heteroplasmy dynamics

Characterization and Management of Arrhythmic Events in Young Patients With Brugada Syndrome

Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.

Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy

Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org)

ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe.

Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls

Ethnic differences in patients with Brugada syndrome and arrhythmic events: New insights from Survey on Arrhythmic Events in Brugada Syndrome

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice ...

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by rep

Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology

Fever-Related Arrhythmic Events in the Multicenter Survey on Arrhythmic Events in Brugada Syndrome (SABRUS).

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

Gating Properties of SCN5A Mutations and the Response to Mexiletine in Long-QT Syndrome Type 3 Patients

Gender differences in patients with Brugada syndrome and arrhythmic events: Data from a survey on arrhythmic events in 678 patients

Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3.

Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice.

Guía ESC 2015 sobre el tratamiento de pacientes con arritmiasventriculares y prevención de la muerte súbita cardiaca

Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica

HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

High Efficacy of β-Blockers in Long-QT Syndrome Type 1

Induced pluripotent stem cell-derived cardiomyocytes and long QT syndrome: is personalized medicine ready for prime time?

Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis

KCNJ2 mutation in short QT syndrome 3 results in atrial fibrillation and ventricular proarrhythmia

Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome

Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome

Long QT syndrome and pregnancy

Long QT syndrome in adults.

Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation

Long-QT syndrome after age 40.

Medical Practice Guidelines Separating science from economics

Modulating effects of age and gender on the clinical course of long QT syndrome by genotype

Outcome parameters for trials in atrial fibrillation: executive summary

Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association

Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome.

Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE

Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE.

Profile of Brugada Syndrome Patients Presenting with Their First Documented Arrhythmic Event. Data from the Survey on Arrhythmic Events in BRUgada Syndrome (SABRUS).

Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group

Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis

Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome

Risk factors for recurrent syncope and subsequent fatal or near-fatal events in children and adolescents with long QT syndrome

Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals

Risk of death in the long QT syndrome when a sibling has died

Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.

Risk stratification in the long-QT syndrome.

Short communication: flecainide exerts an antiarrhythmic effect in a mouse model of catecholaminergic polymorphic ventricular tachycardia by increasing the threshold for triggered activity.

Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age.

Time-to-first appropriate shock in patients implanted prophylactically with an implantable cardioverter-defibrillator: data from the Survey on Arrhythmic Events in BRUgada Syndrome (SABRUS)

Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model

Universal definition of myocardial infarction

Update of the guidelines on sudden cardiac death of the European Society of Cardiology

Viral gene transfer rescues arrhythmogenic phenotype and ultrastructural abnormalities in adult calsequestrin-null mice with inherited arrhythmias

[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the

[Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]

[Guidelines for cardiac pacing and cardiac resynchronization therapy]

[Guidelines in cardiac pacing and resynchronization therapy].

[Guidelines on the management of stable angina pectoris: executive summary]